J Clin Oncol. 1991 Aug;9(8):1403-8.

Improved results with the addition of interferon alfa-2b to dacarbazine in the treatment of patients with metastatic malignant melanoma.

Source

Department of Medical Oncology, University of Pretoria, South Africa.

Abstract

Sixty-four patients with histologically confirmed metastatic malignant melanoma were entered on a prospectively controlled randomized trial. Patients received dacarbazine (DTIC) alone or DTIC plus interferon (IFN) alfa-2b. Patients were reasonably balanced with respect to age, sex, performance status (PS), site of metastases, and number of metastatic sites. Objective response (complete plus partial remission [CR + PR]) was documented in six patients on DTIC and in 16 patients on DTIC plus IFN alfa-2b. Median time to treatment failure (TTF) and median survival are significantly better on the combination arm, with some long-term CRs observed. More toxicity was encountered in the combination arm, which was acceptable except in three patients where treatment was discontinued because of IFN toxicity.

PMID:: 2072144; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Medical

Melanoma - MedlinePlus Health Information

Molecular Biology Databases

DACARBAZINE - HSDB

Supplemental Content

Save items

Related citations in PubMed

Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: an Eastern Cooperative Oncology Group study. [J Clin Oncol. 1998]
Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: an Eastern Cooperative Oncology Group study.
Falkson CI, Ibrahim J, Kirkwood JM, Coates AS, Atkins MB, Blum RH. J Clin Oncol. 1998 May; 16(5):1743-51.
Experience with interferon alpha 2b combined with dacarbazine in the treatment of metastatic malignant melanoma. [Med Oncol. 1995]
Experience with interferon alpha 2b combined with dacarbazine in the treatment of metastatic malignant melanoma.
Falkson CI. Med Oncol. 1995 Mar; 12(1):35-40.
Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b. [J Clin Oncol. 1999]
Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b.
Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL, Seipp CA, Einhorn JH, White DE, Steinberg SM. J Clin Oncol. 1999 Mar; 17(3):968-75.
Review Biochemotherapy in the treatment of metastatic melanoma in selected patients. [Clin Transl Oncol. 2009]
Review Biochemotherapy in the treatment of metastatic melanoma in selected patients.
González Astorga B, Jiménez Rubiano B, Delgado Pérez JR, Valdivia Bautista J, Sánchez Toro C, González Flores E, Luque Caro R, Castellón Rubio V. Clin Transl Oncol. 2009 Jun; 11(6):382-6.
Review Clinical evaluation of interferons in malignant melanoma. [J Invest Dermatol. 1990]
Review Clinical evaluation of interferons in malignant melanoma.
McLeod GR, Thomson DB, Hersey P. J Invest Dermatol. 1990 Dec; 95(6 Suppl):185S-187S.

See reviews... See all...

Cited by 8 PubMed Central articles

Review Immunotherapy of distant metastatic disease. [Ann Oncol. 2009]
Review Immunotherapy of distant metastatic disease.
Schadendorf D, Algarra SM, Bastholt L, Cinat G, Dreno B, Eggermont AM, Espinosa E, Guo J, Hauschild A, Petrella T, et al. Ann Oncol. 2009 Aug; 20 Suppl 6:vi41-50.
Malignant melanoma in a black child: predisposing precursors and management. [J Natl Med Assoc. 2004]
Malignant melanoma in a black child: predisposing precursors and management.
Adedoyin OT, Johnson AW, Ojuawo AI, Afolayan EA, Adeniji KA. J Natl Med Assoc. 2004 Oct; 96(10):1368-73.
Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG). [Br J Cancer. 2001]
Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG).
Hauschild A, Garbe C, Stolz W, Ellwanger U, Seiter S, Dummer R, Ugurel S, Sebastian G, Nashan D, Linse R, et al. Br J Cancer. 2001 Apr 20; 84(8):1036-42.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Improved results with the addition of interferon alfa-2b to dacarbazine in the t...
Improved results with the addition of interferon alfa-2b to dacarbazine in the treatment of patients with metastatic malignant melanoma.
J Clin Oncol. 1991 Aug ;9(8):1403-8.

PubMed
Global and national socioeconomic disparities in obesity, overweight, and underw...
Global and national socioeconomic disparities in obesity, overweight, and underweight status.
J Obes. 2010 ;2010. pii: 514674. Epub 2010 Apr 1 .

PubMed
CSF Biomarkers for Alzheimer's Disease Diagnosis.
CSF Biomarkers for Alzheimer's Disease Diagnosis.
Int J Alzheimers Dis. 2010 Jun 23 ;2010. pii: 606802.

PubMed
Characterisation of dystrophin in carriers of Duchenne muscular dystrophy.
Characterisation of dystrophin in carriers of Duchenne muscular dystrophy.
J Neurol Sci. 1991 Apr ;102(2):197-205.

PubMed
A correction algorithm to simultaneously control dual deformable mirrors in a wo...
A correction algorithm to simultaneously control dual deformable mirrors in a woofer-tweeter adaptive optics system.
Opt Express. 2010 Aug 2 ;18(16):16671-84. doi: 10.1364/OE.18.016671.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Improved results with the addition of interferon alfa-2b to dacarbazine in the treatment of patients with metastatic malignant melanoma.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 8 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information